NEW YORK, USA, June 20, 2023 (Globe Newswire) — According to a newly published report by Research Dive, of global Machine learning in the pharmaceutical industry market is projected to grow at a staggering CAGR of 37.9%, earning money from it $26,151.8 a million in the 2022-2031 time frame. This comprehensive report provides a comprehensive overview of the nature of machine learning in the pharmaceutical industry market including key features such as growth drivers, growth opportunities, constraints and obstacles over the period 2022-2031. The report also includes all necessary and important market figures to help new entrants gain insight into the nature and mechanics of the market.
market dynamics
driver: Rising demand for personalized therapy/behavior modification is expected to be the major growth driver for machine learning in the pharmaceutical industry market during the forecast period. Moreover, increasing adoption of machine learning to accelerate the drug discovery process by identifying potential targets for drug discovery is expected to help the market grow during the forecast period.
chance: Rise in popularity of machine learning in improving medical diagnostics is anticipated to offer numerous growth opportunities to the market during the forecast period. Moreover, increasing use of machine learning to identify biomarkers and other factors is estimated to boost the market growth rate during the forecast period.
Restraint: However, regulatory and legal challenges surrounding machine learning may limit the growth of machine learning in the pharmaceutical industry market.
Request an exclusive PDF sample of the Machine Learning Market in Pharmaceuticals (including tables, table of contents, and figures)
Market Impact of COVID-19
The COVID-19 pandemic has disrupted the daily lifestyles of people around the world, and the ensuing lockdowns have adversely affected industrial processes in all sectors. However, machine learning in the pharmaceutical industry market was positively impacted. There is a growing demand for machine learning techniques to improve the drug discovery process and reduce the time required for clinical trials. This has helped the market record growth rates during the pandemic.
market segment
This report divides the Machine Learning in Pharmaceutical Industry market into specific segments based on component, company size, deployment, and region.
component: Resolutions The subsegments are as follows one of most dominant
The solutions sub-segment is expected to become highly dominant by 2031. Increasing use of machine learning solutions by the pharmaceutical industry to enhance drug development, clinical trials, and personalized treatments is expected to help the market record growth during the forecast period.
E.Company size: Large companies to subsegment offal important market share
The large enterprise sub-segment of machine learning in the pharmaceutical industry market is expected to hold a huge market share during the forecast period. Large pharmaceutical companies are adopting machine learning systems to process clinical trial data, electronic medical records, genomic data, and chemical databases, which is projected to boost the growth rate of this sub-segment.
introduction: cloud from subsegment prosper greatly
The cloud sub-segment is expected to be very profitable by 2031. Increasing utilization of cloud computing for secure and scalable data storage and processing in the pharmaceutical industry is expected to help the market grow during the forecast period.
Ask our expert analysts or schedule a call to get the latest trends in machine learning in the pharmaceutical industry market
Region: Market North America most profitable
Machine learning in the North America region pharmaceutical industry market is projected to be the most profitable within the analysis period. Massive technological developments taking place in the field of machine learning in the countries of the region, especially the United States, are expected to be the major factors for the market growth in the region.
prominent market participants
The prominent market players of Machine Learning in Pharmaceutical Industry market are:
- cyclica Ltd.
- atomwise Ltd.
- International Business Machines Corporation
- Biosymmetry, Inc.
- Alphabet Inc.
- microsoft
- Crowd Pharmaceuticals, Inc.
- NVIDIA Corporation
- IBM
- deep genomics
These companies have developed numerous business strategies such as mergers, acquisitions, and collaborations to gain a dominant position in the market.
Request an on-demand customization for a specific segment or region of machine learning in the pharmaceutical industry market
For example, in January 2023, biotech giant BioNTech announced the acquisition of UK-based AI-based startup InstaDeep. With this acquisition, BioNTech is expected to support drug discovery-related operations and comprehensively meet the demands of the medical field.
Finally, published by Research Dive, the report also provides many key aspects of machine learning in the pharmaceutical industry market including the latest strategic developments, SWOT analysis, financial performance of key players, and product portfolio.
Learn more about machine learning in the pharmaceutical industry market:
